DK0714910T3 - Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud - Google Patents

Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud

Info

Publication number
DK0714910T3
DK0714910T3 DK95402697T DK95402697T DK0714910T3 DK 0714910 T3 DK0714910 T3 DK 0714910T3 DK 95402697 T DK95402697 T DK 95402697T DK 95402697 T DK95402697 T DK 95402697T DK 0714910 T3 DK0714910 T3 DK 0714910T3
Authority
DK
Denmark
Prior art keywords
contg
leu
decapeptide
benzodiazepine
supplements
Prior art date
Application number
DK95402697T
Other languages
Danish (da)
English (en)
Inventor
Laurent Miclo
Emanuel Perrin
Alain Driou
Jean-Francois Boudier
Catherine Iung
Guy Linden
Original Assignee
Cooperative Agricole Laiti Re
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cooperative Agricole Laiti Re filed Critical Cooperative Agricole Laiti Re
Application granted granted Critical
Publication of DK0714910T3 publication Critical patent/DK0714910T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95402697T 1994-11-30 1995-11-30 Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud DK0714910T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9414362A FR2727315A1 (fr) 1994-11-30 1994-11-30 Utilisation d'un decapeptide a activite de type benzodiazepine pour la preparation de medicaments et de complements alimentaires

Publications (1)

Publication Number Publication Date
DK0714910T3 true DK0714910T3 (da) 1999-10-18

Family

ID=9469315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95402697T DK0714910T3 (da) 1994-11-30 1995-11-30 Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud

Country Status (10)

Country Link
US (1) US5846939A (de)
EP (1) EP0714910B1 (de)
JP (1) JP3973244B2 (de)
AT (1) ATE178615T1 (de)
DE (1) DE69508890T2 (de)
DK (1) DK0714910T3 (de)
ES (1) ES2135023T3 (de)
FR (1) FR2727315A1 (de)
GR (1) GR3030650T3 (de)
SI (1) SI0714910T1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465432B1 (en) * 2000-08-28 2002-10-15 Kraft Food Holdings, Inc. Isolated antioxidant peptides form casein and methods for preparing, isolating, and identifying antioxidant peptides
EP1275308A1 (de) * 2001-07-13 2003-01-15 The Procter & Gamble Company Lebensmittelzusammenstellung mit stresslinderenden Eigenschaften für Säugetiere
NL1032322C2 (nl) * 2006-08-15 2008-02-18 Friesland Brands Bv Slaapmelk.
FR2909879B1 (fr) * 2006-12-13 2009-03-13 Lorraine Inst Nat Polytech Utilisation d'un heptapeptide a activite anxiolytique pour la preparation de medicaments et de complements alimentaires
FR2932090B1 (fr) * 2008-06-06 2012-09-14 Lorraine Inst Nat Polytech Compositions anxiolytiques comprenant des peptides derives de la caseine alpha s1
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
CN109310638A (zh) 2016-05-06 2019-02-05 医师印章有限责任公司 缬草组合物和相关方法
US10980269B2 (en) 2016-12-12 2021-04-20 Mead Johnson Nutrition Company Protein hydrolysates and methods of making same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JPH06239888A (ja) * 1993-02-18 1994-08-30 Kanebo Ltd 新規ペプチド及び鎮静剤並びに精神安定用食品

Also Published As

Publication number Publication date
ATE178615T1 (de) 1999-04-15
ES2135023T3 (es) 1999-10-16
EP0714910B1 (de) 1999-04-07
SI0714910T1 (en) 1999-10-31
JP3973244B2 (ja) 2007-09-12
GR3030650T3 (en) 1999-10-29
US5846939A (en) 1998-12-08
EP0714910A1 (de) 1996-06-05
DE69508890T2 (de) 1999-10-07
FR2727315A1 (fr) 1996-05-31
JPH08268903A (ja) 1996-10-15
FR2727315B1 (de) 1997-02-14
DE69508890D1 (de) 1999-05-12

Similar Documents

Publication Publication Date Title
DK207489A (da) Lactalbumin som kosttilskud
NO864556D0 (no) Fremgangsmaate og fremstilling av insulinpreparat.
DE68905387T2 (de) Aminosäure-Nahrungsmittelzusammensetzungen.
ES2159737T3 (es) Composiciones farmaceuticas y/o dieteticas con actividad antioxidante que contienen carnosina o derivados y aminoacidos ramificados.
DK0714910T3 (da) Anvendelse af et decapeptid med aktivitet af benzodiazepintype til fremstilling af medikamenter og kosttilskud
WO1988003150A3 (fr) Preparations aminoacides contenant des peptides de n,n'-bis-l-aminoacide-l-cystine et destinees a l'administration orale et parenterale
IT1216139B (it) Composizione dietetica eprocedimento per la sua preparazione.
NO892744D0 (no) N-terminale aminodiol-aminosyrederivater og fremgangsmaatefor deres fremstilling.
DK0403458T3 (da) Hidtil ukendte polypeptider og anvendelse deraf
DK0482108T3 (da) Substituerede 2-imidazoliner samt fremstilling og anvendelse deraf
DK33989A (da) Farmaceutisk praeparat med psykotrop og/eller anxiolytisk virkning, deri indgaaende forbindelser og disses fremstilling
ES2041932T3 (es) Compuesto proteinico.
DK0975581T3 (da) Til oral administrering egnede faste præparater omfattende L-carnitin eller alkanoyl-L-canitincholintartrat
DE3671630D1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT8920225A0 (it) Integratori dietetici, in particolare per condizioni di accresciuto catabolismo proteico.
ATE53214T1 (de) Glycero-3(2)-phospho-l-serinderivate und diese enthaltende pharmazeutischen praeparate.
IT1215945B (it) Derivato di amminoacido della serie d, sua preparazione e composizioni farmaceutiche che lo contengono per il trattamento del rallentato metabolismo cerebrale.
IT8124088A0 (it) Composizione a base di lisozima in associazione con lisati proteici ed oligoelementi utile per lapreparazione, eventualmente in unione ad alimenti semplici di integratori per l'alimentazione animale.
IT1153208B (it) Procedimento per l'estrazione di sostanze azotate, in particolare proteine e/o amminoacidi da sostanze vegetali, in particolare da sottoprodotti della lavorazione della soia
NO901028L (no) Smaksavleveringssystem for fettfrie matvarer.